DSH-003

DSH-003 is a preclinical-stage biomaterial developed by Cellontech, a South Korean biotechnology company specializing in regenerative medicine. Designed for soft tissue reconstruction and the repair of soft tissue defects, DSH-003 likely leverages Cellontech's core atelocollagen technology. Atelocollagen is a type of collagen processed to remove telopeptides, significantly reducing its immunogenicity while maintaining its structural integrity as a biocompatible scaffold. The product is intended to be applied or injected into defect sites to provide a physical matrix that supports cellular infiltration, proliferation, and the eventual regeneration of native soft tissue.